Jensen Investment Management Inc. Has $11.45 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Jensen Investment Management Inc. lifted its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 21.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 70,495 shares of the company's stock after purchasing an additional 12,340 shares during the quarter. Jensen Investment Management Inc. owned approximately 0.06% of Clorox worth $11,449,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of the company. Ilex Capital Partners UK LLP increased its holdings in Clorox by 512.7% in the 3rd quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company's stock valued at $88,315,000 after buying an additional 453,624 shares during the period. Amundi increased its stake in Clorox by 42.6% in the fourth quarter. Amundi now owns 1,032,283 shares of the company's stock valued at $165,816,000 after acquiring an additional 308,234 shares during the period. Assenagon Asset Management S.A. increased its stake in Clorox by 302.0% in the fourth quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company's stock valued at $57,390,000 after acquiring an additional 265,455 shares during the period. State Street Corp raised its position in Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company's stock worth $1,332,947,000 after purchasing an additional 245,525 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new position in Clorox during the fourth quarter worth about $37,935,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Clorox Trading Up 0.2 %

Clorox stock traded up $0.30 during mid-day trading on Thursday, hitting $145.46. The stock had a trading volume of 1,257,827 shares, compared to its average volume of 1,214,897. The stock has a 50-day simple moving average of $153.40 and a two-hundred day simple moving average of $159.97. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The stock has a market capitalization of $17.92 billion, a PE ratio of 39.74, a P/E/G ratio of 2.62 and a beta of 0.45. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the firm posted $2.16 EPS. As a group, sell-side analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.35%. The ex-dividend date is Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is currently 133.33%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on CLX shares. Wells Fargo & Company increased their target price on Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. Evercore ISI lifted their price objective on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Royal Bank of Canada restated a "sector perform" rating and issued a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. JPMorgan Chase & Co. increased their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. Finally, Barclays boosted their price target on shares of Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a research report on Wednesday, February 5th. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, Clorox has an average rating of "Hold" and an average price target of $159.62.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.